Innovative approach to treating pancreatic cancer combines chemo- and immuno-therapy
VCU Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) researchers discovered a unique approach to treating pancreatic cancer that may be potentially safe and effective. The treatment method involves immunochemotherapy – a combination of chemotherapy and immunotherapy, which uses the patient’s own immune system to help fight against disease. This pre-clinical study, led by Paul B. Fisher, M.Ph., Ph.D., and Luni Emdad, M.B.B.S., Ph.D., found that the delivery of [pIC]PEI – a combination of the already-established immune-modulating molecule, polyinosine-polycytidylic acid (pIC), with delivery molecule polyethlenimine (PEI), a polymer often used in detergents, adhesives and cosmetics – inside pancreatic cancer cells triggers cancer cell death without harming normal pancreatic cells.
Innovative national clinical trial offered at Massey utilizes precision medicine techniques to improve lung cancer treatment
VCU Massey Cancer Center is conducting a novel clinical trial in collaboration with the National Cancer Institute and cancer centers nationwide for patients with squamous cell lung cancer, a type of non-small cell lung cancer with different genetic changes driving the growth of cancerous cells. These genetic changes vary from person to person, and this clinical trial, named Lung-MAP, is unique in offering a targeted approach to better treat the patient.
Chat on precision medicine in lung cancer
Last week, the National Cancer Institute (NCI) hosted a Twitter chat on precision medicine in lung cancer. Danielle Shafer, D.O., hematologist-oncologist, member of the Developmental Therapeutics research program at Massey Cancer Center and assistant professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine, provided expert commentary as Dr. Shakun Malik, head of thoracic oncology therapeutics for the NCI’s Cancer Therapy Evaluation Program, posed a series of questions and discussion topics.
Bradley awarded endowed chair
Cathy J. Bradley, Ph.D., associate director for cancer prevention and control at VCU Massey Cancer Center, has been awarded the Theresa A. Thomas Memorial Foundation Chair in Cancer Prevention and Control in recognition of her exemplary contributions to Massey’s research mission. Bradley also serves as program leader for Massey’s Cancer Prevention and Control research program, founding chair of VCU School of Medicine’s Department of Healthcare Policy and Research and interim chair of VCU’s Department of Social and Behavioral Health. She previously held the RGC Professorship in Cancer Research.
Enter the “Mos for Massey” Social Media Contest!
“Movember” is a campaign that encourages men to grow moustaches during the month of November to help raise awareness for testicular cancer, prostate cancer and mental health issues. VCU Massey Cancer Center invites everyone (men, women and kids!) to join the “Movember” movement and help us raise awareness for men’s cancers by taking part in our “Mos for Massey” contest.